Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Participants in the campaign are invited to share their personal diabetes journeys with Glucerna, in order to gain the ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Tidepool, a software company committed to innovations in diabetes management, is thrilled ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Abbott (NYSE: ABT) today released new data highlighting the emotional challenges faced by people living with type 2 diabetes, ...

Notably, 51% of patients reported not regularly testing their blood sugar levels at home, citing reasons such as inconvenience or a belief that monitoring is unnecessary. Furthermore, the survey ...

Many of us with loved ones living with diabetes want to see them thrive. We often think of ways we can ease some of their ...

For instance, the Medical Devices segment experienced a 13.6 percent increase in sales, driven by growth in Diabetes Care and ...

We are excited to partner with Abbott to empower healthcare providers and people living with diabetes to see data from their FreeStyle Libre devices on Tidepool and Tidepool+,” said Brandon ...